Inventor · disambiguated record
Michael D. Altman
Also filed as: ALTMAN MICHAEL · ALTMAN MICHAEL D
56 granted patents·11 pending applications·292 citations·filing 2007–2021
98Inventor score
Top patents by PatentIndex Score
67 records- 0197US10106574B2Cyclic di-nucleotide compounds as sting agonistsMERCK SHARP & DOHME·Filed 2016·Granted Oct 23, 2018·34 cites·34 claims
- 0294US10766919B2Cyclic di-nucleotide compounds as sting agonistsMERCK SHARP & DOHME·Filed 2018·Granted Sep 8, 2020·9 cites·15 claims
- 0393US10759825B2Cyclic di-nucleotide compounds as STING agonistsMERCK SHARP & DOHME·Filed 2018·Granted Sep 1, 2020·6 cites·22 claims
- 0493US10738074B2Cyclic di-nucleotide compounds as STING agonistsMERCK SHARP & DOHME·Filed 2016·Granted Aug 11, 2020·8 cites·10 claims
- 0593US9006444B2Phenyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitorsMERCK SHARP & DOHME·Filed 2012·Granted Apr 14, 2015·13 cites·10 claims
- 0693US8987456B23-pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitorsMERCK SHARP & DOHME·Filed 2012·Granted Mar 24, 2015·15 cites·17 claims
- 0793US8735417B2Aminopyrimidines as Syk inhibitorsALTMAN MICHAEL D·Filed 2010·Granted May 27, 2014·35 cites·13 claims
- 0892US8551984B2Aminopyrimidines as SYK inhibitorsALTMAN MICHAEL D·Filed 2010·Granted Oct 8, 2013·25 cites·40 claims
- 0991US10414747B2Benzo[b]thiophene compounds as sting agonistsMERCK SHARP & DOHME·Filed 2017·Granted Sep 17, 2019·9 cites·27 claims
- 1091US9969749B2Inhibitors of IRAK4 activityMERCK SHARP & DOHME·Filed 2015·Granted May 15, 2018·6 cites·4 claims
- 1191US9242984B2Pyrazolyl derivatives as Syk inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Jan 26, 2016·12 cites·21 claims
- 1290US9932350B2Inhibitors of IRAK4 activityMERCK SHARP & DOHME·Filed 2015·Granted Apr 3, 2018·5 cites·5 claims
- 1389US9216173B22-Pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitorsALTMAN MICHAEL D·Filed 2012·Granted Dec 22, 2015·8 cites·16 claims
- 1488US10793557B2Sting agonist compoundsMERCK SHARP & DOHME·Filed 2019·Granted Oct 6, 2020·4 cites·43 claims
- 1588US10730849B2Benzo[b]thiophene compounds as STING agonistsMERCK SHARP & DOHME·Filed 2019·Granted Aug 4, 2020·3 cites·13 claims
- 1688US9943516B2Inhibitors of IRAK4 activityMERCK SHARP & DOHME·Filed 2015·Granted Apr 17, 2018·5 cites·8 claims
- 1788US9926330B2Inhibitors of IRAK4 activityMERCK SHARP & DOHME·Filed 2015·Granted Mar 27, 2018·5 cites·5 claims
- 1888US9120785B2Pyridyl aminopyridines as Syk inhibitorsALTMAN MICHAEL D·Filed 2012·Granted Sep 1, 2015·13 cites·13 claims
- 1987US9290490B2Aminopyrimidines as Syk inhibitorsALTMAN MICHAEL D·Filed 2012·Granted Mar 22, 2016·12 cites·25 claims
- 2086US10040798B2Pyrrolopyridazine inhibitors of IRAK4 activityMERCK SHARP & DOHME·Filed 2016·Granted Aug 7, 2018·3 cites·4 claims
- 2184US11453697B1Cyclic di-nucleotide compounds as sting agonistsMERCK SHARP & DOHME·Filed 2020·Granted Sep 27, 2022·1 cites·10 claims
- 2283US10703738B2Benzo[b]thiophene compounds as STING agonistsMERCK SHARP & DOHME·Filed 2019·Granted Jul 7, 2020·3 cites·6 claims
- 2383US10246457B2Indazole and azaindazole Btk inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Apr 2, 2019·2 cites·8 claims
- 2483US9221809B2Aminopyrimidinones as interleukin receptor-associated kinase inhibitorsMERCK SHARP & DOHME·Filed 2012·Granted Dec 29, 2015·4 cites·3 claims
- 2581US9145391B2Bipyridylaminopyridines as Syk inhibitorsDESCHENES DENIS·Filed 2012·Granted Sep 29, 2015·10 cites·13 claims
- 2680US9376418B2Substituted pyridine spleen tyrosine kinase (SYK) inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Jun 28, 2016·5 cites·18 claims
- 2779US8367706B2Inhibitors of janus kinasesMERCK SHARP & DOHME·Filed 2008·Granted Feb 5, 2013·5 cites·8 claims
- 2878US9416111B2Substituted diazine and triazine spleen tyrosine kinease (Syk) inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Aug 16, 2016·4 cites·20 claims
- 2976US8415346B2Inhibitors of Janus kinasesALTMAN MICHAEL·Filed 2009·Granted Apr 9, 2013·4 cites·8 claims
- 3075US8962611B2Substituted imidazopyridines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Feb 24, 2015·1 cites·20 claims
- 3175US8846657B2Substituted imidazopyridines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Sep 30, 2014·1 cites·30 claims
- 3275US8349865B2Inhibitors of janus kinasesMERCK SHARP & DOHME·Filed 2008·Granted Jan 8, 2013·3 cites·7 claims
- 3375US8278335B2Inhibitors of Janus kinasesMACHACEK MICHELLE R·Filed 2009·Granted Oct 2, 2012·4 cites·9 claims
- 3474US10155765B2Carboxamide inhibitors of IRAK4 activityMERCK SHARP & DOHME·Filed 2016·Granted Dec 18, 2018·1 cites·11 claims
- 3573US9730940B2Purine inhibitors of human phosphatidylinositol 3-kinase deltaMERCK SHARP & DOHME·Filed 2013·Granted Aug 15, 2017·3 cites·9 claims
- 3671US9487504B2Imidazolyl analogs as syk inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Nov 8, 2016·1 cites·7 claims
- 3771US9169260B2Amidopyrazole inhibitors of interleukin receptor-associated kinasesMCELROY WILLIAM T·Filed 2012·Granted Oct 27, 2015·4 cites·7 claims
- 3871US8592425B2Imidazo[1,2-a]pyridines and imidazo[1,2-b]pyridazines as mark inhibitorsALTMAN MICHAEL D·Filed 2010·Granted Nov 26, 2013·2 cites·17 claims
- 3970US10329294B2Pyrazolopyrimidine inhibitors of IRAK4 activityMERCK SHARP & DOHME·Filed 2016·Granted Jun 25, 2019·1 cites·5 claims
- 4070US10329295B2Pyrrolotriazine inhibitors of IRAK4 activityMERCK SHARP & DOHME·Filed 2016·Granted Jun 25, 2019·1 cites·8 claims
- 4166US8946237B2Pyrazolo[1,5-A]pyrimidines as mark inhibitorsLIM JONGWON·Filed 2011·Granted Feb 3, 2015·1 cites·11 claims
- 4262US8329722B2Inhibitors of janus kinases and/or 3-phosphoinositide-dependent protein kinase-1SIU TONY·Filed 2008·Granted Dec 11, 2012·1 cites·9 claims
- 4356US2014243290A1Aminopyrimidines as SYK InhibitorsALTMAN MICHAEL D·Filed 2014·Application pending·0 cites
- 4454US11098059B2PRMT5 inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Aug 24, 2021·0 cites·3 claims
- 4552US9598405B2Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Mar 21, 2017·0 cites·14 claims
- 4651US9745295B2Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Aug 29, 2017·0 cites·10 claims
- 4750US2023257371A1Cyclic cyanoenone derivatives as modulators of keap1ALTMAN MICHAEL·Filed 2021·Application pending·0 cites
- 4849US12441730B2PRMT5 inhibitorsMERCK SHARP & DOHME LLC·Filed 2020·Granted Oct 14, 2025·0 cites·14 claims
- 4948US9783531B2Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Oct 10, 2017·0 cites·8 claims
- 5047US2022024964A1Cyclic Di-Nucleotide Compounds as STING AgonistsMERCK SHARP & DOHME·Filed 2019·Application pending·0 cites
Showing the top 50 of 67 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael D. Altman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →